South Korea · Delayed Price · Currency is KRW XIIlab Co.,Ltd Statistics
Total Valuation
XIIlab Co.,Ltd has a market cap or net worth of KRW 141.67 billion. The enterprise value is 121.80 billion.
| Market Cap | 141.67B |
| Enterprise Value | 121.80B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
XIIlab Co.,Ltd has 9.38 million shares outstanding. The number of shares has increased by 47.53% in one year.
| Current Share Class | 9.38M |
| Shares Outstanding | 9.38M |
| Shares Change (YoY) | +47.53% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 31.52% |
| Owned by Institutions (%) | n/a |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.91 |
| PB Ratio | 6.77 |
| P/TBV Ratio | 6.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.80, with a Debt / Equity ratio of 0.01.
| Current Ratio | 9.80 |
| Quick Ratio | 9.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -168.52 |
Financial Efficiency
Return on equity (ROE) is -37.79% and return on invested capital (ROIC) is -23.64%.
| Return on Equity (ROE) | -37.79% |
| Return on Assets (ROA) | -20.49% |
| Return on Invested Capital (ROIC) | -23.64% |
| Return on Capital Employed (ROCE) | -25.90% |
| Weighted Average Cost of Capital (WACC) | 14.96% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.70 |
| Inventory Turnover | 69.41 |
Taxes
In the past 12 months, XIIlab Co.,Ltd has paid 1.14 million in taxes.
| Income Tax | 1.14M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +146.73% in the last 52 weeks. The beta is 1.95, so XIIlab Co.,Ltd's price volatility has been higher than the market average.
| Beta (5Y) | 1.95 |
| 52-Week Price Change | +146.73% |
| 50-Day Moving Average | 10,929.40 |
| 200-Day Moving Average | 6,806.10 |
| Relative Strength Index (RSI) | 56.43 |
| Average Volume (20 Days) | 665,882 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, XIIlab Co.,Ltd had revenue of KRW 11.90 billion and -5.38 billion in losses. Loss per share was -598.00.
| Revenue | 11.90B |
| Gross Profit | 2.57B |
| Operating Income | -5.56B |
| Pretax Income | -5.38B |
| Net Income | -5.38B |
| EBITDA | -4.59B |
| EBIT | -5.56B |
| Loss Per Share | -598.00 |
Balance Sheet
The company has 20.02 billion in cash and 151.78 million in debt, with a net cash position of 19.87 billion or 2,118.11 per share.
| Cash & Cash Equivalents | 20.02B |
| Total Debt | 151.78M |
| Net Cash | 19.87B |
| Net Cash Per Share | 2,118.11 |
| Equity (Book Value) | 20.92B |
| Book Value Per Share | 2,229.39 |
| Working Capital | 19.86B |
Cash Flow
In the last 12 months, operating cash flow was -3.78 billion and capital expenditures -908.57 million, giving a free cash flow of -4.69 billion.
| Operating Cash Flow | -3.78B |
| Capital Expenditures | -908.57M |
| Depreciation & Amortization | 965.15M |
| Net Borrowing | -677.99M |
| Free Cash Flow | -4.69B |
| FCF Per Share | -499.60 |
Margins
Gross margin is 21.62%, with operating and profit margins of -46.71% and -45.19%.
| Gross Margin | 21.62% |
| Operating Margin | -46.71% |
| Pretax Margin | -45.18% |
| Profit Margin | -45.19% |
| EBITDA Margin | -38.60% |
| EBIT Margin | -46.71% |
| FCF Margin | n/a |
Dividends & Yields
XIIlab Co.,Ltd does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.53% |
| Shareholder Yield | -47.53% |
| Earnings Yield | -3.79% |
| FCF Yield | -3.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 15, 2021. It was a forward split with a ratio of 2.
| Last Split Date | Sep 15, 2021 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
XIIlab Co.,Ltd has an Altman Z-Score of 11.33 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.33 |
| Piotroski F-Score | 4 |